Biosimilars Canada Boss Calls For Ontario Switching Policy
Jim Keon Urges Ontario To Follow Other Provinces And Adopt Biosimilar Switching Program
Biosimilars Canada president Jim Keon has urged the province of Ontario to follow other Canadian provinces by adopting a biosimilar switching policy for its public drug program, in order to cut costs on biologics and re-invest in the healthcare system.
